RETRACTED: Risk Factors of Arteriovenous Fistula Stenosis of Patients with Maintenance Hemodialysis (Retracted Article)

被引:4
|
作者
Gao, Meiling [1 ]
Wang, Jing [1 ]
机构
[1] Changzhou Second Peoples Hosp, Blood Purificat Ctr, Changzhou 213000, Jiangsu, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE;
D O I
10.1155/2022/2968122
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To investigate the risk factors of arteriovenous fistula stenosis in maintenance hemodialysis patients. Methods. A total of 80 patients with maintenance hemodialysis in our hospital from January 2017 to January 2022 were included. According to the stenosis degree of the arteriovenous fistula, patients were divided into a stenosis group (n = 35) and an unobstructed group (n = 45). Laboratory examination data, such as the demographic characteristics of patients, past medical history, the use of traditional Chinese medicine (TCM), the TCM for improving blood circulation to promote blood circulation and remove blood stasis, and cellular immune function, were collected. Multivariate Logistic regression analysis was used to analyze the influencing factors. Results. There was no significant difference in the age, sexuality, body mass index, proportion of patients with coronary heart disease, cephalic vein diameter, radial artery diameter, albumin, fibrinogen, and blood calcium levels between the two groups (P > 0.05). Compared with the unobstructed group, the stenosis group had higher rates of diabetes and hypertension as well as significantly higher levels of platelets, parathyroid hormone, and D-dimer (P < 0.05). The proportion of TCM application in the stenosis group was 28.6% (10/35), which was significantly lower than that in the unobstructed group 57.8% (26/45). The difference was statistically significant (chi(2) = 6.785, P=0.009). The levels of CD3+ (37.5 +/- 5.1% vs. 42.0 +/- 4.8%), CD4+ (35.7 +/- 3.2% vs. 39.6 +/- 3.1%) and CD4+/CD8+ (1.4 +/- 0.3 vs. 2.4 +/- 1.0) in the stenosis group were significantly lower, while CD8+ level was significantly higher (26.8 +/- 5.1% vs. 18.5 +/- 6.2%) than that in the unobstructed group (P < 0.001). Logistic regression analysis indicated that the usage of TCM was an independent risk factor for arteriovenous fistula stenosis after adjustment for other factors (odds ratio [OR] 0.302; 95% confidence interval [95% CI] 0.100-0.896; P=0.039). Conclusions. Less use of traditional Chinese medicine for activating blood circulation and removing blood stasis and poor cellular immune function are important factors affecting the function of the arteriovenous fistula in patients with maintenance hemodialysis, which is worthy of clinical attention.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] RETRACTED: Effects of High Flux Hemodialysis Combined with L-Carnitine on Microinflammation and Arteriovenous Fistula in Maintenance Hemodialysis Patients (Retracted Article)
    Zhou, Yunhong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] RETRACTED: A Retrospective Case-Control Study on Late Failure of Arteriovenous Fistula in Hemodialysis Patients and Prediction of Risk Factors (Retracted Article)
    Ge, Liang
    Fang, Yu
    Rao, Shaofeng
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [3] RETRACTED: To Explore the Application of PDCA in Hemodialysis Center and Its Effect on the Maintenance of Internal Fistula (Retracted Article)
    Su, Xiaomei
    Cui, Yihong
    Pu, Zunguo
    Zhou, Yaqing
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [4] RETRACTED: Analysis of Different Vascular Accesses on Dialysis Quality and Infection Risk Factors of Hemodialysis Patients (Retracted Article)
    Wu, Huaping
    Li, Xiang
    Zeng, Cunliang
    Zhang, Li
    Song, Huanhuan
    Lv, Kaiping
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [5] RETRACTED: Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis (Retracted Article)
    Song, Xiaowen
    Qiu, Hancheng
    Wang, Shuo
    Cao, Yong
    Zhao, Jizong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [6] RETRACTED: Imaging Diagnosis and Interventional Treatment for Hepatocellular Carcinoma Combined with Arteriovenous Fistula (Retracted Article)
    Cai, Zheng
    Ran, Maohui
    Song, Jiantao
    Zhen, Wenrui
    Li, Mingjian
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [7] RETRACTED: Risk Factors and Treatments of Suprachoroidal Hemorrhage (Retracted Article)
    Jiang, Huaiyan
    Gao, Yang
    Fu, Wenzhong
    Xu, Hongxia
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [8] The risk factors for arteriovenous fistula dysfunction in maintenance hemodialysis patients: A cross-sectional study
    Zhang, Fan
    Yu, Jie
    Li, Guoli
    Fu, Shuangshuang
    Xiao, Hailang
    Yang, Yiya
    Liang, Yumei
    Chen, Yinyin
    Luo, Xun
    HEMODIALYSIS INTERNATIONAL, 2024, 28 (02) : 170 - 177
  • [9] Risk factors of arteriovenous fistula thrombosis in the patients on chronic hemodialysis
    Jahromi, Alireza Hamidian
    Roozbeh, Jamshid
    Serati, Ali
    Jalali, Ghanbar-Ali Raiss
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 151 - 151
  • [10] RETRACTED: Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients (Retracted Article)
    He, Haidong
    Xie, Yan
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020